Pharmacy Benefit Management

From Drug Benefit News - Contrave (naltrexone HCl and bupropion HCl) last month joined the growing category of anti-obesity medications available by prescription in the U.S. (DBN 10/24/14, p. 8). Read more

From Drug Benefit News - Putting a new spin on the narrow pharmacy network trend, CVS Health’s PBM may soon penalize customers who choose to obtain prescriptions from other tobacco-selling locations through the creation of what could be the first tobacco-free pharmacy network. While CVS/caremark says the network is being developed in response to client demand, several benefit consultants that work with large plan sponsors tell DBN they haven’t observed a need for this kind… Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - November 21, 2014
The topic of formulary exclusions has been getting a lot of attention lately and was the subject of a panel discussion at last week’s National Business Coalition on Health conference that raised a lot of good questions and considerations for plan sponsors. For example, employers wonder whether...
By Lauren Flynn Kelly - November 12, 2014
Yesterday I had a chance to attend the National Business Coalition on Health’s 19th Annual Conference in Washington, D.C. One common thread I noticed throughout the day was a reminder from speakers that we weren’t just talking about controlling and reducing health care costs but about improving...
By Angela Maas - November 4, 2014
When Vertex Pharmaceuticals Inc.’s Incivek (telaprevir) and Merck & Co., Inc.’s Victrelis (boceprevir) launched in the U.S. in June 2011, they were hailed as the first oral therapies to treat hepatitis C. Offering a higher cure rate than the previous regimen of pegylated interferon and...

It's quick and easy to sign up for FREE access to!

Why do I need to register?